CA Stock MarketDetailed Quotes

Cosciens Biopharma Inc (CSCI)

Watchlist
  • 1.900
  • -0.210-9.95%
15min DelayMarket Closed Mar 12 16:00 ET
6.05MMarket Cap-0.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cosciens Biopharma Inc (CSCI) Revenue Breakdown Overview

By Business/Source

Currency:USD
2024/FY
Stock NameRevenueRatio
Active ingredient8.49M88.58%
Pharmaceutical1.1M11.42%

By Product

No Data

By Industry

No Data

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States6.69M69.79%
Germany1.36M14.19%
United Kingdom976K10.18%
Colombia300K3.13%
Other260K2.71%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.94%
Sample Name
Sample Code
 +8.86%
Sample Name
Sample Code
 +4.51%
4
TRIP.COM-S
09961
+4.41%
5
BABA-W
09988
+4.20%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.65%
Sample Name
Sample Code
 +1.93%
Sample Name
Sample Code
 +0.85%
4
Morningstar
MORN
+0.84%
5
Vistra Energy
VST
+0.26%
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -